Keywords: Prostate, Prostate, Tumor, Synthetic MRI, APT, CEST, MUSE DWI, multiparameter MRI
Motivation: Prostate cancer is the second most common malignant tumor among elderly men worldwide.
Goal(s): To evaluate the diagnostic efficacy of combining Synthetic MRI, Amide Proton Transfer (APT) imaging, and Multiplexed Sensitivity Encoding DWI (MUSE DWI) in distinguishing between benign and malignant prostate lesions.
Approach: 37 patients were enrolled (16 with malignant tumors, 21 with benign lesions). T1, T2, PD, APT, and ADC were measured and analyzed.
Results: All models based on multiparametric MRI outperformed individual indicators, with the highest AUC of 0.958 achieved by the model combining T1, T2, APT, and ADC.
Impact: This study demonstrates the clinical value of using multiparametric MRI, incorporating Synthetic MRI, APT, and MUSE DWI, for improving differentiation between benign and malignant prostate diseases.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords